Lenalidomide therapy in patients with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)

Maura Nicolosi; Mythri Mudireddy; Rangit Vallapureddy; Naseema Gangat; Ayalew Tefferi; Mrinal M. Patnaik

doi:10.1002/ajh.24952

Lenalidomide therapy in patients with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)

Maura Nicolosi, Mythri Mudireddy, Rangit Vallapureddy, Naseema Gangat, Ayalew Tefferi, Mrinal M. Patnaik

Hematology

Research output: Contribution to journal › Letter › peer-review

12 Scopus citations

Original language	English (US)
Pages (from-to)	E27-E30
Journal	American journal of hematology
Volume	93
Issue number	1
DOIs	https://doi.org/10.1002/ajh.24952
State	Published - Jan 2018

ASJC Scopus subject areas

Hematology

Access to Document

10.1002/ajh.24952

Cite this

@article{68c891d2cff342f79afbb3888b0c6d64,

title = "Lenalidomide therapy in patients with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)",

author = "Maura Nicolosi and Mythri Mudireddy and Rangit Vallapureddy and Naseema Gangat and Ayalew Tefferi and Patnaik, {Mrinal M.}",

note = "Funding Information: Gerstner Family Career Development Award, Mayo Clinic Center for Individualized Medicine; Mayo Clinic, Rochester, MN, USA; CTSA Grant Number KL2 TR000136 from the National Center for Advancing Translational Science (NCATS).",

year = "2018",

month = jan,

doi = "10.1002/ajh.24952",

language = "English (US)",

volume = "93",

pages = "E27--E30",

journal = "American journal of hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "1",

}

TY - JOUR

T1 - Lenalidomide therapy in patients with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)

AU - Nicolosi, Maura

AU - Mudireddy, Mythri

AU - Vallapureddy, Rangit

AU - Gangat, Naseema

AU - Tefferi, Ayalew

AU - Patnaik, Mrinal M.

N1 - Funding Information: Gerstner Family Career Development Award, Mayo Clinic Center for Individualized Medicine; Mayo Clinic, Rochester, MN, USA; CTSA Grant Number KL2 TR000136 from the National Center for Advancing Translational Science (NCATS).

PY - 2018/1

Y1 - 2018/1

UR - http://www.scopus.com/inward/record.url?scp=85037686797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037686797&partnerID=8YFLogxK

U2 - 10.1002/ajh.24952

DO - 10.1002/ajh.24952

M3 - Letter

C2 - 29067707

AN - SCOPUS:85037686797

SN - 0361-8609

VL - 93

SP - E27-E30

JO - American journal of hematology

JF - American journal of hematology

IS - 1

ER -

Lenalidomide therapy in patients with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this